|
Legaz I, Boix F, Lopez M, Alfaro R, Galian JA, Llorente S, Campillo JA, Botella C, Ramirez P, Sanchez-Bueno F, Pons JA, Moya-Quiles MR, Minguela A, Muro M. Influence of Preformed Antibodies in Liver Transplantation. J Clin Med. 2020 Mar 5;9(3):708. doi: 10.3390/jcm9030708. PubMed PMID: 32151032; PubMed Central PMCID: PMC7141359.
AÑO: 2020; IF: 4.964
|
|
Vega-Garcia N, Benito R, Esperanza-Cebollada E, Llop M, Robledo C, Vicente-Garces C, Alonso J, Barragan E, Fernandez G, Hernandez-Sanchez JM, Martin-Izquierdo M, Maynou J, Minguela A, Montano A, Ortega M, Torrebadell M, Cervera J, Sanchez J, Jimenez-Velasco A, Riesco S, Hernandez-Rivas JM, Lassaletta A, Fernandez JM, Rives S, Dapena JL, Ramirez M, Camos M, On Behalf Of The Group Of Leukemia Of The Spanish Society Of Pediatric Hematology And Oncology Sehop. Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia. J Pers Med. 2020 Nov 26;10(4):244. doi: 10.3390/jpm10040244. PubMed PMID: 33255984; PubMed Central PMCID: PMC7711852.
AÑO: 2020; IF: 4.945
|
|
Gimeno L, Serrano-Lopez EM, Campillo JA, Canovas-Zapata MA, Acuna OS, Garcia-Cozar F, Martinez-Sanchez MV, Martinez-Hernandez MD, Soto-Ramirez MF, Lopez-Cubillana P, Martinez-Escribano J, Martinez-Garcia J, Corbalan-Garcia S, Alvarez-Lopez MR, Minguela A. KIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profiling. Cancers (Basel). 2020 Oct 15;12(10):2991. doi: 10.3390/cancers12102991. PubMed PMID: 33076479; PubMed Central PMCID: PMC7650600.
AÑO: 2020; IF: 6.639
|
|
Vega-Garcia N, Perez-Jaume S, Esperanza-Cebollada E, Vicente-Garces C, Torrebadell M, Jimenez-Velasco A, Ortega M, Llop M, Abad L, Vagace JM, Minguela A, Pratcorona M, Sanchez-Garcia J, Garcia-Calderon CB, Gomez-Casares MT, Martin-Clavero E, Escudero A, Rinon Martinez-Gallo M, Munoz L, Velasco MR, Garcia-Morin M, Catala A, Pascual A, Velasco P, Fernandez JM, Lassaletta A, Fuster JL, Badell I, Molinos-Quintana A, Molines A, Guerra-Garcia P, Perez-Martinez A, Garcia-Abos M, Robles Ortiz R, Pisa S, Adan R, Diaz de Heredia C, Dapena JL, Rives S, Ramirez-Orellana M, Camos M. Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment. Front Pediatr. 2021 Feb 5;8:614521. doi: 10.3389/fped.2020.614521. eCollection 2020. PubMed PMID: 33614543; PubMed Central PMCID: PMC7892614.
AÑO: 2020; IF: 3.418
|
32151032